5th Edition of India Biopharma Leaders Conclave to be Held on 5th-6th June at Le Meridien, Hyderabad

Hyderabad, India – The 5th Edition of the India Biopharma Leaders Conclave is scheduled for June 5th and 6th, 2025, at Le Meridien, Hyderabad. This year’s theme is “New Horizons in Biopharma, Biosimilars, & Biologics.”

The conclave aims to explore exciting new opportunities and advancements in the biopharmaceutical sector, especially in biosimilars and biologics. Participants can expect insightful discussions on the latest research and development, regulatory updates, market trends, and innovative manufacturing practices in these fields.

Industry leaders and experts from across the globe will come together to share their knowledge and experiences. The event will also cover important topics such as improving access to affordable biopharmaceuticals, maintaining quality and safety standards, and overcoming challenges in the biopharma industry.

Why Should You Attend?

Attending the conclave offers valuable insights into the rapidly evolving biopharma landscape, including how innovation, regulatory changes, and compliance challenges shape the industry’s future. It provides a unique platform to network with peers and potential collaborators, helping attendees expand their professional connections. The event is also an excellent opportunity to discover new products, technologies, and services driving progress in biopharma. 

More importantly, the conclave encourages the exchange of knowledge and ideas through interactive sessions that could spark collaborations and shape the industry's path forward. Participants will also engage in meaningful discussions on common industry challenges such as regulatory hurdles, complex research and development processes, competitive market dynamics, and ethical considerations.

Key Topics To Be Highlighted At The Event: 

Key topics for this edition include an in-depth look at the next wave of biosimilars, focusing on future prospects and the challenges faced during development. Discussions will highlight how biosimilars must adhere to the same stringent quality, safety, and efficacy standards as all biological medicines. The future of cell and gene therapy manufacturing will also be explored, alongside why maintaining robust quality standards is critical for biologics and biosimilars. 

Attendees will be able to learn about emerging trends and technologies in quality assurance, the importance of digitalised supply chains, and the role of a strong digital backbone in the biopharma industry. The event will reflect on the ongoing consolidation trend in the sector and examine the advances and barriers impacting the future of CAR-T cell therapies.

Advisory Board Members: 

The conclave’s Advisory Board comprises esteemed experts including Dr. Tathagata Dutta, Chief Scientific Officer (CSO) at Refex Life Sciences; Dr. Subhash Thuluva, Senior Vice President and Head of Clinical Development at Biological E Limited; and Dr. Ranjan Chakrabrati, Consultant specialising in R&D strategy, biologics, drug discovery, and biopharma. Along with these distinguished leaders, the event will feature 10 renowned speakers sharing their insights and expertise.

For more details about the event, please visit https://bluetech-media.com/iblc! 

Pharma Now: The Media Partner

Pharma Now is proud to be the official media partner for the 5th Edition of the India Biopharma Leaders Conclave. For all the latest updates, detailed information, and event coverage, visit Pharma Now and stay connected with the forefront of biopharma innovation.